7-butyl-3-(3-chloro-4-(cyclopropylmethoxy)phenyl)-[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one

ID: ALA5220917

Chembl Id: CHEMBL5220917

PubChem CID: 168299101

Max Phase: Preclinical

Molecular Formula: C19H21ClN4O2

Molecular Weight: 372.86

Names and Identifiers

Canonical SMILES:  CCCCn1ccn2c(-c3ccc(OCC4CC4)c(Cl)c3)nnc2c1=O

Standard InChI:  InChI=1S/C19H21ClN4O2/c1-2-3-8-23-9-10-24-17(21-22-18(24)19(23)25)14-6-7-16(15(20)11-14)26-12-13-4-5-13/h6-7,9-11,13H,2-5,8,12H2,1H3

Standard InChI Key:  HEXHCZJMUFBSRY-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5220917

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 372.86

Molecular Weight (Monoisotopic): 372.1353

AlogP: 3.80

#Rotatable Bonds: 7

Polar Surface Area: 61.42

Molecular Species: NEUTRAL

HBA: 6

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 3.56

CX LogD: 3.56

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.63

Np Likeness Score: -1.63

References

1. Callis TB, Garrett TR, Montgomery AP, Danon JJ, Kassiou M..  (2022)  Recent Scaffold Hopping Applications in Central Nervous System Drug Discovery.,  65  (20.0): [PMID:36206553] [10.1021/acs.jmedchem.2c00969]

Source

Source(1):

• Scientific Literature